MIT researchers created a nanosensor catheter that detects bladder cancer biomarkers far earlier than current tests.

Anktiva is now approved for BCG-unresponsive papillary-only bladder cancer. Here’s what the bladder-sparing option involves, from timeline to risks. For people with non-muscle invasive bladder cancer ...

Researchers in China have built an explainable deep learning model that analyzes contrast-enhanced CT scans to predict ...